Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 2949 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 4060 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 4496 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 4656 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 4919 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 4969 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 5043 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 5215 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 5984 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6146 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6216 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6284 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6296 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6376 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6403 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6571 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6715 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6809 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6870 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6893 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 6922 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7101 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7261 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7400 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7411 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7502 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7506 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7524 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7548 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7710 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7754 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7918 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 7971 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8032 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8065 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8150 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8189 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8198 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8366 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8431 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8468 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8592 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 8979 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9085 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9355 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9605 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9662 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9685 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9750 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9849 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9859 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 9950 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10437 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10481 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10515 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10517 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10689 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10698 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10743 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10836 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10909 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 10964 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11095 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11237 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11374 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11462 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11467 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11665 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11728 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 11933 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12268 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12273 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12303 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12394 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12436 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 12790 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13091 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13140 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13172 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13465 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13470 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13476 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13879 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 13960 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 14015 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 14196 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 14711 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 15268 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 15407 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 15755 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 16319 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 16731 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 16768 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 17231 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 18072 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 18451 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 18806 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 19394 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | 20844 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | TYROSINE (CAS# 60-18-4); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 1694419 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 1718638 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 1807746 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 1940189 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2024857 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2030393 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2058340 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2087453 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2091172 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2130352 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2140071 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2159572 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2190964 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2293139 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2309875 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2335385 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2385418 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2399381 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2401258 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2449295 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2450735 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2490031 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2544708 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2560817 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2578035 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2600223 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2650139 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2693940 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2770150 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2780734 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2785302 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2798755 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2868841 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2877801 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2882473 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2895262 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2897390 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2914720 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2931389 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 2972750 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3039472 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3152447 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3169018 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3171414 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3180029 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3183021 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3207464 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3304172 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3306313 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3307044 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3355710 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3382433 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3442291 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3596195 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3608613 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3636220 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3646986 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3657139 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3676855 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3677383 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3691728 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3691989 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3704562 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3724777 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3802154 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3810085 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3821540 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3827136 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3831318 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3851918 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3907304 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3933398 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 3940697 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4010162 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4029812 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4078031 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4084880 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4168794 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4176342 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4178902 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4190056 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4222383 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4238879 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4245370 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4287898 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4313631 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4426035 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4604596 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4613512 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4866579 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 4881407 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5032205 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5096238 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5146913 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5387759 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5445226 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5589944 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5643687 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 5680789 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TYROSINE (CAS# 60-18-4); (M+H)+ | 6412997 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Return to search page